Fundraising Fox
/Companies
Sign in

SeqOne

5 known investors

Find your way into SeqOne

Each arrow is one introduction. Sign up to fill in the first one.

115 people can intro you to Nicolas

Ask Guillaume Thoviste to introduce you to Nicolas Philippe

You →Guillaume · together at SeqOne →Nicolas

Sign up to find every way you can get introduced to SeqOne

  • Your email: who you already know at SeqOne, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SeqOne team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing. It offers tools such as a DiagAI variant-prioritization score and an automated data pipeline (SeqOne Flow), serving diagnostic labs and clinical genomics teams with a CE-IVD certified in vitro diagnostic medical device.

AI & Machine LearningBiotechDigital Health

Founders & leadership

NPNicolas Philippe
Nicolas PhilippeFounder, CPSO & PresidentNicolas Philippe has worked on high-throughput (NGS) sequencing since beginning his PhD in 2007, spanning mathematical and computational analysis of sequencing data, bioinformatics tool development, and a postdoctoral focus on biomedical problems and genomic biomarker discovery. He founded SeqOne in March 2017, a company offering a bioinformatics platform for analyzing genetic sequencing data in medical laboratories.

Investors · 5

Mérieux Equity Partnerslisted by Mérieux Equity PartnersParis · $3.2M – $86M
PSL Innovation Fundlisted by PSL Innovation FundParis

How we know: PSL Innovation Fund's portfolio page · Not right? Tell us

Supernova Investlisted by Supernova InvestParis

How we know: funding news · the VCSheet dataset · Not right? Tell us

ElaiareportedParis · $108K – $1.6M

How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

SeqOne Secures €20M Growth Funding | The SaaS Newsthesaasnews.com · May 2025

Frequently asked questions

What does SeqOne do?
SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing. It offers tools such as a DiagAI variant-prioritization score and an automated data pipeline (SeqOne Flow), serving diagnostic labs and clinical genomics teams with a CE-IVD certified in vitro diagnostic medical device.
Who founded SeqOne?
SeqOne was founded by Nicolas Philippe.
Who are SeqOne's investors?
SeqOne's investors include Korys, Mérieux Equity Partners, PSL Innovation Fund, Supernova Invest, Elaia.